Evidence map›Paper›PMID 10688894›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Viral persistence in vivo through selection of neutralizing antibody-escape variants.

A Ciurea, P Klenerman, L Hunziker, E Horvath, B M Senn, A F Ochsenbein, H Hengartner, R M Zinkernagel

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 146 citations in OpenAlex.

  1. Article
  2. Article
  3. A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Experimental Reptarenavirus Infection ofJournal of virology · 2021
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Comprehensive Review of HumanFrontiers in immunology · 2019
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Genetic conflicts: the usual suspects and beyond.The Journal of experimental biology · 2017
    Review
  15. Article
  16. Arenavirus Quasispecies and Their Biological Implications.Current topics in microbiology and immunology · 2016
    Review
  17. Article
  18. Review
  19. Viral quasispecies evolution.Microbiology and molecular biology reviews : MMBR · 2012
    Review
  20. Immunological memory ≠ protective immunity.Cellular and molecular life sciences : CMLS · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

A CiureaInstitute for Experimental Immunology, University Hospital, CH-8091 Zurich, Switzerland. aciurea@pathol.unizh.ch
P Klenerman
L Hunziker
E Horvath
B M Senn
A F Ochsenbein
H Hengartner
R M Zinkernagel
University Hospital of Zurich · CH

Funding

Wellcome Trust
6 · The paper itself

Abstract

Despite initial virus control by CD8(+) cytotoxic T lymphocytes (CTLs), noncytopathic or variably cytopathic viruses (e.g., hepatitis B and C viruses, HIV) are able to establish persistent infections. The role of neutralizing antibodies (nAbs) in controlling disease progression is unclear. Therefore, the phenomenon of viral evasion from the nAb response and its implications for virus persistence remain controversial. Here we demonstrate nAb-mediated viral clearance in CTL-deficient mice infected with the prototypic noncytopathic lymphocytic choriomeningitis virus (strain WE). During prolonged CTL absence, neutralization-resistant virus mutants were selected in individual mice within 70-90 days. In naive animals infected with these virus variants only low nAb responses were induced, resulting in an increased tendency of virus to persist.

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, ViralCD8 AntigensCD8-Positive T-LymphocytesLungLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, Inbred BALB CMice, Inbred C57BLPoint MutationSpleenTime FactorsT-Lymphocytes, CytotoxicAntibodies, MonoclonalAntibodies, ViralCD8 Antigens

Identifiers

PMID10688894
PMCPMC16001
OpenAlexW1987028100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.